Veterinary medicine lags decades behind humans. Personal experience with this gap is what motivates us to close it.

Kedi is a startup focused on advancing the veterinary application of drug mechanisms which revolutionized care of challenging human diseases.

We discover novel biologic molecules and specifically tailor them to cats. Kedi’s fully feline drug candidates aim to give veterinarians the precision arsenal they need to treat life-threatening and chronic diseases.